ASP Isotopes Inc. Common Stock
Financials
Valuation Metrics
ASP Isotopes Inc. Common Stock's Market Cap is $309M. At end of 2025 it was $474M. Ranked #2894 of 3,116 in US market (top 93%), #1303 of 1,472 on NASDAQ (top 89%), #164 of 173 in Materials (top 95%) by Market Cap.
Investment Metrics(as of 2026-10-30)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $309M | US#2,894/3,116 Sec#164/173 |
| Revenue | $27M | US#2,779/3,116 Sec#153/173 |
| Net Income | $-132M | US—/3,116 Sec—/173 |
| Total Assets | $572M | US#2,705/3,116 Sec#152/173 |
| Net Assets | $265M | US#2,561/3,116 Sec#150/173 |
| Employees | 271 | US#2,425/3,116 Sec#133/173 |
| Value | ||
| P/B | 1.17x | US#639/3,116 Sec#32/173 |
| P/S | 11.36x | US#2,742/3,116 Sec#150/173 |
| FCF Yield | -27.05% | US—/3,116 Sec—/173 |
| Profitability | ||
| ROE | -49.89% | US#2,671/3,116 Sec#159/173 |
| ROA | -23.08% | US#2,825/3,116 Sec#162/173 |
| Op. Margin | -354.20% | US#2,769/3,116 Sec#154/173 |
| Revenue Growth | 516.49% | US#27/3,116 Sec#1/173 |
| Financial Health | ||
| Debt Ratio | 112.30% | US#1,198/3,116 Sec#103/173 |
| Total Debt | $270M | US#2,127/3,116 Sec#121/173 |
| FCF | $-84M | US#2,604/3,116 Sec#148/173 |
| Cash | $220M | US#1,658/3,116 Sec#101/173 |
| Current Ratio | 3.87x | US#589/3,116 Sec#29/173 |
| Performance | ||
| 1Y Return | -81.27% | US#3,073/3,116 Sec#170/173 |
| 1M Return | -23.96% | US#2,870/3,116 Sec#154/173 |
| From 52W High | -86.09% | US#3,088/3,116 Sec#171/173 |
| 1Y MDD | -86.12% | US#3,082/3,116 Sec#171/173 |
| Trading | ||
| Volume | 3,128,911 shares | US#507/3,116 Sec#35/173 |
| Trading Value | $6M | US#2,421/3,116 Sec#137/173 |
| Per Share | ||
| EPS | $-0.86 | US—/3,116 Sec—/173 |
| BPS | $1.73 | US#2,591/3,116 Sec#146/173 |
Company Info
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.